Your browser doesn't support javascript.
loading
The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
Schmieder, Roland E; Wagner, Frank; Mayr, Michael; Delles, Christian; Ott, Christian; Keicher, Christian; Hrabak-Paar, Maja; Heye, Tobias; Aichner, Solveig; Khder, Yasser; Yates, Denise; Albrecht, Diego; Langenickel, Thomas; Freyhardt, Patrick; Janka, Rolf; Bremerich, Jens.
Affiliation
  • Schmieder RE; Department of Nephrology and Hypertension, University Hospital Erlangen, Ulmenweg 18, 91054 Erlangen, Germany.
  • Wagner F; Charité Research Organisation, Berlin, Charité Research Organisation GmbH, Charitéplatz 1, 10117 Berlin (Mitte), Germany.
  • Mayr M; Outpatient Department, University Hospital Basel, Basel, Switzerland.
  • Delles C; Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
  • Ott C; Department of Nephrology and Hypertension, University Hospital Erlangen, Ulmenweg 18, 91054 Erlangen, Germany.
  • Keicher C; Charité Research Organisation, Berlin, Charité Research Organisation GmbH, Charitéplatz 1, 10117 Berlin (Mitte), Germany.
  • Hrabak-Paar M; Outpatient Department, University Hospital Basel, Basel, Switzerland.
  • Heye T; University Hospital Center Zagreb, University of Zagreb School of Medicine, Kispaticeva 12 (Rebro), 10 000 Zagreb, Croatia.
  • Aichner S; Outpatient Department, University Hospital Basel, Basel, Switzerland.
  • Khder Y; Outpatient Department, University Hospital Basel, Basel, Switzerland.
  • Yates D; Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland.
  • Albrecht D; Novartis Institutes for BioMedical Research, Inc., 250 Massachusetts Avenue, Cambridge, MA 02139, USA.
  • Langenickel T; Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland.
  • Freyhardt P; Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland.
  • Janka R; Charité Research Organisation, Berlin, Charité Research Organisation GmbH, Charitéplatz 1, 10117 Berlin (Mitte), Germany.
  • Bremerich J; Department of Radiology, University Hospital Erlangen, Maximiliansplatz 1, 91054 Erlangen, Germany.
Eur Heart J ; 38(44): 3308-3317, 2017 Nov 21.
Article in En | MEDLINE | ID: mdl-29029087
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Ventricular Remodeling / Angiotensin Receptor Antagonists / Vascular Stiffness / Aminobutyrates / Imidazoles / Antihypertensive Agents Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur Heart J Year: 2017 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Ventricular Remodeling / Angiotensin Receptor Antagonists / Vascular Stiffness / Aminobutyrates / Imidazoles / Antihypertensive Agents Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur Heart J Year: 2017 Type: Article Affiliation country: Germany